NFSG
SRPT icon

Newbridge Financial Services Group’s Sarepta Therapeutics SRPT Stock Holding History

Newbridge Financial Services Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Hold
1,000
– – ﹤0.01% 733
2026
Q1 		$21.8K Hold
1,000
– – ﹤0.01% 620
2025
Q4 		$21.5K Hold
1,000
– – ﹤0.01% 625
2025
Q3 		$19.3K Sell
1,000
-50
-5% -$891 ﹤0.01% 756
2025
Q2 		$18K Buy
1,050
+750
+250% +$32K ﹤0.01% 748
2025
Q1 		$19.1K Hold
300
– – ﹤0.01% 554
2024
Q4 		$36.5K Buy
+300
New +$36.8K 0.01% 478
2024
Q3 		– Sell
-300
Closed -$47.4K – 1050
2024
Q2 		$47.4K Hold
300
– – 0.02% 389
2024
Q1 		$38.8K Hold
300
– – 0.02% 447
2023
Q4 		$28.9K Sell
300
-43
-13% -$4.13K 0.01% 515
2023
Q3 		$41.6K Sell
343
-300
-47% -$33.9K 0.02% 456
2023
Q2 		$73.6K Hold
643
– – 0.04% 368
2023
Q1 		$88.6K Hold
643
– – 0.05% 335
2022
Q4 		$83.3K Hold
643
– – 0.05% 334
2022
Q3 		$71K Sell
643
-168
-21% -$16.9K 0.04% 368
2022
Q2 		$61K Sell
811
-382
-32% -$28.1K 0.04% 362
2022
Q1 		$93K Buy
1,193
+35
+3% +$2.68K 0.05% 319
2021
Q4 		$104K Sell
1,158
-150
-11% -$12.8K 0.05% 299
2021
Q3 		$121K Buy
1,308
+50
+4% +$3.85K 0.08% 245
2021
Q2 		$98K Buy
1,258
+83
+7% +$6.29K 0.06% 287
2021
Q1 		$88K Buy
1,175
+575
+96% +$53.1K 0.06% 277
2020
Q4 		$102K Hold
600
– – 0.08% 224
2020
Q3 		$84K Buy
+600
New +$91.2K 0.08% 218

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Newbridge Financial Services Group's SRPT Position: Q2 2026 in Review

Newbridge Financial Services Group held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 1,000 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Newbridge Financial Services Group first reported a position in SRPT in Q3 2020 and has held it in 23 quarters since. The position peaked at $121K in Q3 2021. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Newbridge Financial Services Group held 1,000 shares of Sarepta Therapeutics worth $18K as of Q2 2026.
  • Newbridge Financial Services Group left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #733 holding.
  • Newbridge Financial Services Group first reported a position in Sarepta Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Newbridge Financial Services Group's Sarepta Therapeutics position peaked at $121K in Q3 2021.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.